# Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

> **NCT07087080** · NA · RECRUITING · sponsor: **Hasselt University** · enrollment: 350 (estimated)

## Conditions studied

- Solitary Pulmonary Nodules
- Lung Cancer

## Interventions

- **OTHER:** Blood sampling

## Key facts

- **NCT ID:** NCT07087080
- **Lead sponsor:** Hasselt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-02
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07087080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07087080, "Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07087080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*